| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $56.5M | $40.8M | $28.9M |
| YoY Revenue Growth % | +38.6% | +41.1% | — |
| Gross Profit | $12.0M | $9.2M | — |
| Gross Margin % | 21.3% | 22.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $364.6K | -$19.4M | -$10.9M |
| Operating Margin % | 0.6% | -47.6% | -37.8% |
| Net Income (GAAP) | -$7.0M | -$9.0M | -$11.6M |
| EBITDA (Normalized) | $375.8K | -$19.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $7.9M | -$13.8M | -$3.9M |
| Capital Expenditures (CapEx) | $14.0K | $1.7K | — |
| Free Cash Flow (FCF) | $7.9M | -$13.8M | -$3.9M |
| FCF Margin % | 13.9% | -34.0% | -13.6% |
| Return on Invested Capital (ROIC %) | 0.2% | -15.0% | — |
| Cash & Short-Term Equivalents | $262.3M | $118.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $382.8M | $220.3M | — |